Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Full year 2022 report and securing finances for US commercialization

NeoDynamics

NeoDynamics Full year report 2022 with all consolidated entities and the company secures financing for the launch of NeoNavia in the US.

Read full year report here: https://www.neodynamics.com/sv-se/tools/GetCisionNews?id=4469196&lang=eng

NeoDynamics announced yesterday that they secured financing for the launch of NeoNavia in the US from their largest shareholder Gryningkust Holding AB. 

Read announcement with full transparency on terms for the loan here: https://www.neodynamics.com/sv-se/tools/GetCisionNews?id=4468681&lang=eng

Sigup to Q&A event with CFO Aaron Wong on the above topics plus rollout plans for the commercialization in US - Monday the 20th. of February 1 PM.  here: https://hcandersencapital.dk/event/neodynamics-presentation-of-annual-accounts-2022/

HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. /Analyst Claus Thestrup 4:40 PM 02-17-2022.

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.